San Diego, CA, United States of America

Jose E Gonzales

This inventor holds 1 USPTO granted patent. Top assignee: The Immune Response Corporation. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jose E. Gonzales in Viral Inhibition

Introduction

Jose E. Gonzales is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of virology through his innovative work on antisense constructs. His research focuses on developing methods to inhibit viral production, particularly in the context of hepatitis B virus (HBV).

Latest Patents

Jose E. Gonzales holds a patent for "Antisense constructs directed against viral post-transcriptional regulatory sequences." This patent discloses antisense constructs that are designed to hybridize with viral cis-acting post-transcriptional regulatory elements (PREs). These constructs can effectively inhibit the export of viral transcripts from the nucleus to the cytoplasm, thereby reducing viral production.

Career Highlights

Throughout his career, Gonzales has been associated with The Immune Response Corporation, where he has worked on various projects aimed at combating viral infections. His expertise in molecular biology and virology has positioned him as a key figure in the development of innovative therapeutic strategies.

Collaborations

Jose E. Gonzales has collaborated with notable professionals in his field, including Charles R. Ill. These collaborations have further enhanced his research and contributed to the advancement of antiviral technologies.

Conclusion

Jose E. Gonzales is a pioneering inventor whose work on antisense constructs has the potential to significantly impact the treatment of viral infections. His contributions to the field of virology exemplify the importance of innovation in addressing global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…